Quality of life
We offer a wide selection of natural products with scientific foundation to help our customers overcome mild diseases and live the best life possible.
We will grow our business with innovation, trustworthy brand and top quality products. We will act responsibly to both people and nature.
We are building a Nordic brand that people trust and look for when they are suffering from mild diseases. Our customers and health care professionals will be devoted to the brand and love to spread our message.
Quality of life, trust and collaboration are our core values. They will ensure successful and trustworthy relationship with our stakeholders, and are the foundation for our strategy and success. The values permeate our goals, our products and our way of working.
Quality of life – Trust – Collaboration
The Florealis’ management team consists of individuals with varied backgrounds who all share a common passion for increasing professionalism and quality within the herbal medicine industry.
The team’s experience within the pharmaceutical and medical industry covers most facets of the process of bringing product from the lab to the market.
Kolbrún has a solid background within the pharmaceutical industry and has an extensive knowledge of drug development. Her experience in business strategy and international business development are essential part of her contribution to the team. She believes that key success factors in business are clear goals, good planning and effective teamwork.
Karl has extensive experience in sales, marketing, product management and brand building within the medical field. In recent years he has been an executive in international medical device companies such as Ossur, Biomet and Ekso Bionics. Karl has lead several successful efforts in bringing new medical technologies and products to the markets, both in Europe and the US.
Elsa holds a M.Sc. degree in Pharmacy and Ph.D. degree in Natural Product Chemistry from the University of Iceland. She has experience from both the academy and pharmaceutical industry. Before joining Florealis she worked in the R&D department of Actavis as a clinical scientist, with earlier experience as a project manager and stability scientist.
Margrét holds a M.Sc. degree in Pharmacy and a Ph.D. degree in Biomedical Sciences from the University of Iceland. In her previous role as a Qualified Person at Actavis, she gained valuable experience in the pharma industry. For the last few years Margrét has been part of the academic field both as a scientist and as a Research manager at the School of Health Sciences at the University of Iceland.
Daði is an experienced accounting and finance professional, with background in investment banking and corporate finance in different sectors. He holds an M.Sc. degree in Finance from Copenhagen Business School/National University of Singapore, and M.acc. degree from the University of Iceland.
Louise has over twenty years of sales and marketing experience in the Nordic pharmaceutical market as well as category management in pharmacy chains.
Sandra Mjöll is an innovation driven professional with a Ph.D. degree in Biomedical Science. Before joining Florealis she co-founded and ran a biotech company for several years. Her experience with combining science and business provides her with a unique skillset that gives her great insight into the product lifecycle.
Our Board of Directors has four experienced veterans of the pharmaceutical, biotech and venture industries.
Mrs Eggertsdóttir is an experienced executive in pharmaceuticals who served on the executive team of Actavis for decades and is now on the board of several healthcare and pharmaceutical companies.
Mr. Pálsson is a CPA and a board member on several companies and investment funds. He was the CFO of global orthopeadics company Ossur.
Ms Magnúsdóttir is the CEO of the investment fund NSA ventures and has extensive business knowledge and experience in innovation, strategy and international operations after working world wide.
Mr. Ólafsson is the managing director and founder of Arcticus.vc. He has been involved in the development and funding of innovation companies for more than 20 years.